I might not be articulating my point super well since this is HN and I hate typing long drawout thoughts on boards. That being said I understand the situations are different but to me, the sentiment still feels like it should be applied?
On one hand you have the FTC fining a company for violations of data sharing, which I am assuming of the one of the concerns is patient privacy. Which to me, seems like a net good thing. Again I would prefer it to be more, but better then not doing nothing at all I suppose.
On the other hand, you have one giant company with access to mounds of consumer data purchasing even more sensitive healthcare data without even a blink of the eye.
Why was this not challenged? Why fine one company? I might be overthinking it but it seems like a misalignment of priorities. The point of the FTC is to protect consumers, shouldn't both have been investigated? I guess that was the point I was trying to make. Idk, I feel like I'm just rambling at this point.